Pro-opiomelanocortin (POMC), Proprotein Convertase Subtilisin/Kexin Type 1 (PCSK1) and Leptin Receptor (LepR) Gene Mutations
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Genetic Testing and Phenotypic Characterization of Severely Obese Pediatric and Adult Volunteers (NCT02849977) | Rhythm Pharmaceuticals, Inc. | 2016-09-28 |
Track Pro-opiomelanocortin (POMC), Proprotein Convertase Subtilisin/Kexin Type 1 (PCSK1) and Leptin Receptor (LepR) Gene Mutations automatically
Every clearance here is in the API, with alerts when new ones post.